
Basic Protective Measures Against COVID-19
COVID-19 is a new strain of the common cold that has been p...
COVID-19 is a new strain of the common cold that has been p...
Cerezyme (Imiglucerase) for Injection is indicated to treat a certain rare genetic problem. It is called Gaucher disease. It is a genetic disorder in which the body lacks the enzyme needed to break down certain fatty materials. It is called lipids that can build up in the body that causes symptoms such as:
This medication improves bone, blood, and liver spleen problems. This does not correct the genetic problem and treatment must continue for life.
Cerezyme (Imiglucerase) for Injection works inside the lysosome. It is a specialized compartment of the cell where the breakdown of glucocerebroside usually happens. Glucocerebroside is broken down into glucose and ceramide. This can be then removed from the cell by natural processes.
Cerezyme (Imiglucerase) replaces a certain natural substance that is missing in people with Gaucher’s disease. Those natural substances are enzymes called glucocerebrosidase. This product is supplied as a sterile, non-pyrogenic, and white to off-white lyophilized. The Food and Drug Administration (FDA) has already approved this medicine.
Cerezyme (Imiglucerase) for Injection is given by intravenous infusion. It is delivered directly into your bloodstream. This medication typically takes 1-2 hours. It is usually given every two weeks.
The recommended dosage is based on your medical condition and response to it. It is important to take it exactly as it is prescribed. Before using this medicine, check this product visually for particles or discoloration. If it is present, do not use it anymore.